198 related articles for article (PubMed ID: 37623004)
21. Differential response in patients with large cell neuroendocrine carcinoma of the lung to initial therapy: A case series.
Takahara Y; Tanaka T; Ishige Y; Shionoya I; Yamamura K; Sakuma T; Nishiki K; Nakase K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Mizuno S
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1754. PubMed ID: 36366956
[TBL] [Abstract][Full Text] [Related]
22. Large-cell neuroendocrine carcinoma of the lung.
Fernandez FG; Battafarano RJ
Cancer Control; 2006 Oct; 13(4):270-5. PubMed ID: 17075564
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L
Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209
[TBL] [Abstract][Full Text] [Related]
24. Update on large cell neuroendocrine carcinoma.
Hiroshima K; Mino-Kenudson M
Transl Lung Cancer Res; 2017 Oct; 6(5):530-539. PubMed ID: 29114469
[TBL] [Abstract][Full Text] [Related]
25. Molecular Subtypes of High-Grade Neuroendocrine Carcinoma (HGNEC): What is YAP1-Positive HGNEC?
Kawai H; Matsuoka R; Ito T; Matsubara D
Front Biosci (Landmark Ed); 2022 Mar; 27(3):108. PubMed ID: 35345340
[TBL] [Abstract][Full Text] [Related]
26. Systemic treatment for neuroendocrine non-small cell lung carcinoma: A cases series and a systematic review of the literature.
Jelli B; Brandão M; Mekinda Z; Durieux V; Berghmans T
Lung Cancer; 2023 Jul; 181():107232. PubMed ID: 37216840
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma.
Saghaeiannejad Esfahani H; Vela CM; Chauhan A
Front Oncol; 2021; 11():653153. PubMed ID: 34141612
[TBL] [Abstract][Full Text] [Related]
28. Pathologic diagnosis of large cell neuroendocrine carcinoma of the lung in an axillary lymph node: a case report with immunohistochemical and molecular genetic studies.
Terada T
Int J Clin Exp Pathol; 2013; 6(6):1177-9. PubMed ID: 23696939
[TBL] [Abstract][Full Text] [Related]
29. Durable response to combination radiotherapy and immunotherapy in EP-resistant lung large-cell neuroendocrine carcinoma with
Qin Y; Yu M; Zhou L; Jiang L; Huang M
Immunotherapy; 2020 Mar; 12(4):223-227. PubMed ID: 32156177
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy.
Fasano M; Della Corte CM; Papaccio F; Ciardiello F; Morgillo F
J Thorac Oncol; 2015 Aug; 10(8):1133-41. PubMed ID: 26039012
[TBL] [Abstract][Full Text] [Related]
31. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
[TBL] [Abstract][Full Text] [Related]
32. Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution Experience.
Vrontis K; Economidou SC; Fotopoulos G
Cancer Invest; 2022 Feb; 40(2):124-131. PubMed ID: 34601985
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant chemotherapy combined with immunotherapy for pulmonary large-cell neuroendocrine carcinoma: a case report.
Chen F; Hua H; Huang H
Ann Palliat Med; 2021 Jul; 10(7):8479-8483. PubMed ID: 34118833
[TBL] [Abstract][Full Text] [Related]
34. Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges.
Andrini E; Marchese PV; De Biase D; Mosconi C; Siepe G; Panzuto F; Ardizzoni A; Campana D; Lamberti G
J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268551
[TBL] [Abstract][Full Text] [Related]
35. Lung neuroendocrine neoplasms: recent progress and persistent challenges.
Rekhtman N
Mod Pathol; 2022 Jan; 35(Suppl 1):36-50. PubMed ID: 34663914
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer?
Sun JM; Ahn MJ; Ahn JS; Um SW; Kim H; Kim HK; Choi YS; Han J; Kim J; Kwon OJ; Shim YM; Park K
Lung Cancer; 2012 Aug; 77(2):365-70. PubMed ID: 22579297
[TBL] [Abstract][Full Text] [Related]
37. Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study (JLGK1401).
Kawabe T; Yamamoto M; Sato Y; Yomo S; Kondoh T; Nagano O; Serizawa T; Tsugawa T; Okamoto H; Akabane A; Aita K; Sato M; Jokura H; Kawagishi J; Shuto T; Kawai H; Moriki A; Kenai H; Iwai Y; Gondo M; Hasegawa T; Yasuda S; Kikuchi Y; Nagatomo Y; Watanabe S; Hashimoto N
J Neurosurg; 2016 Dec; 125(Suppl 1):11-17. PubMed ID: 27903179
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of Rb1, cyclin D1 and p16 immunohistochemistry expression to distinguish lung small-cell carcinoma and large-cell neuroendocrine carcinoma.
Papaxoinis G; Bille A; McLean E; Nonaka D
Histopathology; 2022 Aug; 81(2):205-214. PubMed ID: 35544410
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary Combined Large Cell Neuroendocrine Carcinoma.
Li M; Yang L; Lu H
Pathol Oncol Res; 2022; 28():1610747. PubMed ID: 36507119
[TBL] [Abstract][Full Text] [Related]
40. Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?
Derks JL; Dingemans AC; van Suylen RJ; den Bakker MA; Damhuis RAM; van den Broek EC; Speel EJ; Thunnissen E
Histopathology; 2019 Mar; 74(4):555-566. PubMed ID: 30485478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
